BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Lorlatinib

0+ PubMed studies analyzed

Similar Compounds by Shared Targets

The following compounds share molecular targets with Lorlatinib, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

repotrectinib
7 shared targets
selitrectinib
5 shared targets
entrectinib
8 shared targets
larotrectinib
4 shared targets
ceritinib
11 shared targets
rociletinib
5 shared targets
asp
10 shared targets
hesperadin
5 shared targets
gw632580x
3 shared targets
bdb
3 shared targets
Loading evidence profile...

This evidence profile for Lorlatinib is generated deterministically from 0 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.